- Home
- FOCL
as of 08-19-2026 1:02pm EST
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
| Founded: | N/A | Country: | France |
| Employees: | N/A | City: | 69120 VAULX EN VELIN |
| Market Cap: | 203.7M | IPO Year: | 1998 |
| Target Price: | N/A | AVG Volume (30 days): | 174.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.63 | EPS Growth: | -41.82 |
| 52 Week Low/High: | $4.09 - $6.40 | Next Earning Date: | N/A |
| Revenue: | $70,527,000 | Revenue Growth: | 1.63% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -6.76 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Stock Insider Trading Activity of EDAP TMS S.A. American Depositary Shares (FOCL)
Director
Avg Cost/Share
$4.75
Shares
10,000
Total Value
$47,500.00
Owned After
15,100
SEC Form 4
Director
Avg Cost/Share
$4.75
Shares
50,000
Total Value
$237,500.00
Owned After
1,291,780
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$4.75
Shares
21,000
Total Value
$99,750.00
Owned After
626,649
SEC Form 4
General Counsel & Corp Sec
Avg Cost/Share
$4.75
Shares
5,000
Total Value
$23,750.00
Owned After
72,500
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Schulz Fran | FOCL | Director | Aug 14, 2026 | Buy | $4.75 | 10,000 | $47,500.00 | 15,100 | |
| WILLSEY LANCE | FOCL | Director | Aug 14, 2026 | Buy | $4.75 | 50,000 | $237,500.00 | 1,291,780 | |
| Rhodes Ryan | FOCL | Chief Executive Officer | Aug 14, 2026 | Buy | $4.75 | 21,000 | $99,750.00 | 626,649 | |
| Shah Sanket | FOCL | General Counsel & Corp Sec | Aug 14, 2026 | Buy | $4.75 | 5,000 | $23,750.00 | 72,500 |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K Aug 13, 2026
Q2 2026 Earnings
8-KAug 13, 2026
2026 Q2 Q2 2026 Earnings
8-K Aug 11, 2026
Q2 2026 Earnings
8-KAug 11, 2026
2026 Q1 Q1 2026 Earnings
8-K May 7, 2026
Q1 2026 Earnings
8-KMay 7, 2026
Compare FOCL vs Leading Stocks
See how FOCL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "FOCL EDAP TMS S.A. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.